Upcoming Events
There are currently no events scheduled
Past Events
| 11 Sep 2009 |
Thomas Lynch, Chairman and CEO webcast
Thomas Lynch, Chairman and CEO presented at the 11th Annual Rodman & Renshaw Healthcare Conference on Friday, September 11, 2009. The presentation can be heard by selecting the webcast link.
|
Webcast
|
| 2 Apr 2009 |
April 2-3 2009 BioTrinity 2009, Oxford UK
Amarin attended the BioTrinity 2009 conference in Oxford, UK on April 2-3, 2009. BioTrinity is the UK’s Premier Biotechnology and Investment Conference.
|
|
| 26 Mar 2009 |
Lippert/Heilshorn Life Sciences and Medical Technologies Conference Presentation
Webcast by Amarin Chairman and CEO, Thomas Lynch, at 11 am Eastern, March 26, 2009 available by selecting the webcast link.
|
Webcast |
| 18 Mar 2009 |
29th Annual Cowen & Co. Health Care Conference
Thomas Lynch, Chairman and Chief Executive Officer will present at The Cowen & Company Conference at 08.00am Eastern Time , March 18, 2009. The presentation can be heard by selecting the webcast link.
|
Webcast |
| 9 Feb 2009 |
11th Annual BIO CEO & Investor Conference
Thomas Lynch, Chairman and Chief Executive Officer presentation at BIO CEO Conference at 2.45 pm Eastern Time , February 9 2009. The presentation can be heard by selecting the webcast link.
|
Webcast |
| 21 Nov 2008 |
Video Interview
Veteran business journalist Sasha Salama joins Amarin Chairman and Chief Executive Officer, Mr. Thomas Lynch to discuss the company's strategic objectives and lead program, AMR101 for hypertriglyceridemia. © Copyright 2005, The NASDAQ OMX Group, Inc. All Rights Reserved.
|
Videocast |
| 11 Nov 2008 |
10th Annual Rodman & Renshaw Healthcare Conference
Darren Cunningham, EVP Strategic Development and Investor Relations at Amarin, presented at the 10th Annual Rodman & Renshaw Healthcare Conference on Tuesday, November 11 at 10.45 am Eastern time. The presentation can be heard by selecting the webcast link.
|
Webcast |
| 25 Sep 2008 |
Amarin Announces Second Quarter 2008 Results Conference Call
Thomas Lynch, Chairman and Chief Executive Officer, Alan Cooke, President and Chief Operating Officer and Dr. Declan Doogan, Head of Research and Development can be heard by dialling (866) 385 3632 (tollfree) in the U.S. and Canada or +1 (706) 679 8931 (toll) elsewhere. Conference ID 65022355.
|
Webcast |
Statements made at each past event speak only as of the date of such
event. Any forward-looking statements are subject to the risks relating
to Amarin identified in its public securities filings. Amarin assumes no
obligation to update statements made at such events. Please see our
Press Releases for information on recent developments at Amarin.
